Literature DB >> 3874595

Covalent binding of moxalactam to cephalosporinase of Citrobacter freundii.

K Murakami, T Yoshida.   

Abstract

The inhibition of Citrobacter freundii cephalosporinase activity by moxalactam is shown to be due to the formation of a transiently stable covalent complex, probably acyl enzyme. The covalent complex formed was identified by coelution of [14C] moxalactam with the enzyme by using Sephadex G-25 gel filtration in the presence of 5.7 M guanidine hydrochloride and by analytical isoelectric focusing. Both the side-chain carboxyl group and the 7 alpha-methoxy group of moxalactam were necessary to stabilize the complex. Moxalactam is racemic with respect to the alpha carbon of the 7 beta-acylamino side chain, and the complex with the R epimer (half-life, 4.6 min) decomposed much more rapidly than that formed with the S epimer (half-life, 130 min). For other beta-lactam antibiotics that were stable to beta-lactamase, the half-lives of enzyme-antibiotic complexes were less than 4 min.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3874595      PMCID: PMC180142          DOI: 10.1128/AAC.27.5.727

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  6-beta-bromopenicillanic acid, a potent beta-lactamase inhibitor.

Authors:  R F Pratt; M J Loosemore
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

Review 2.  The beta-lactamases of gram-negative bacteria and their possible physiological role.

Authors:  M H Richmond; R B Sykes
Journal:  Adv Microb Physiol       Date:  1973       Impact factor: 3.517

Review 3.  Protein denaturation.

Authors:  C Tanford
Journal:  Adv Protein Chem       Date:  1968

Review 4.  The biochemistry and function of beta-lactamase (penicillinase).

Authors:  N Citri; M R Pollock
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1966

5.  CP-45,899, a beta-lactamase inhibitor that extends the antibacterial spectrum of beta-lactams: initial bacteriological characterization.

Authors:  A R English; J A Retsema; A E Girard; J E Lynch; W E Barth
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

6.  The beta-lactamase stability of a novel beta-lactam antibiotic containing a 7 alpha-methoxyoxacephem nucleus.

Authors:  M H Richmond
Journal:  J Antimicrob Chemother       Date:  1980-07       Impact factor: 5.790

7.  beta-Lactamase proceeds via an acyl-enzyme intermediate. Interaction of the Escherichia coli RTEM enzyme with cefoxitin.

Authors:  J Fisher; J G Belasco; S Khosla; J R Knowles
Journal:  Biochemistry       Date:  1980-06-24       Impact factor: 3.162

8.  Beta-lactamase-directed barrier for penicillins of Escherichia coli carrying R plasmids.

Authors:  T Yamamoto; T Yokota
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

9.  Chemical studies on the inactivation of Escherichia coli RTEM beta-lactamase by clavulanic acid.

Authors:  R L Charnas; J Fisher; J R Knowles
Journal:  Biochemistry       Date:  1978-05-30       Impact factor: 3.162

10.  Moxalactam (6059-S), a novel 1-oxa-beta-lactam with an expanded antibacterial spectrum: laboratory evaluation.

Authors:  T Yoshida; S Matsuura; M Mayama; Y Kameda; S Kuwahara
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

View more
  5 in total

1.  Preferential hydrolysis of cis configuration compounds at the 3,4 position of monobactams by beta-lactamase from Morganella morganii.

Authors:  K Matsuda; M Sanada; S Nakagawa; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

2.  Effect of the 3'-leaving group on turnover of cephem antibiotics by a class C beta-lactamase.

Authors:  L J Mazzella; R F Pratt
Journal:  Biochem J       Date:  1989-04-01       Impact factor: 3.857

Review 3.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

4.  In vitro activity of S-3578, a new broad-spectrum cephalosporin active against methicillin-resistant staphylococci.

Authors:  Takaji Fujimura; Yoshinori Yamano; Isamu Yoshida; Jingoro Shimada; Shogo Kuwahara
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

5.  7 alpha-formylamino substituent confers beta-lactamase-inactivating potency on 1-oxacephalosporins.

Authors:  K Murakami; M Doi; T Yoshida
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.